In the only publication describing the effects of chronic administration of a MAGL inhibitor, JZL184 (8 mg/kg; i.p.) given for 10 days normalized the enhanced SBP determined in a mouse model for the Williams-Beuren syndrome [21]. The gene discussed is MGLL; the disease is Williams syndrome.